Cargando…

Development of a syngeneic mouse model of epithelial ovarian cancer

BACKGROUND: Most cases of ovarian cancer are epithelial in origin and diagnosed at advanced stage when the cancer is widely disseminated in the peritoneal cavity. The objective of this study was to establish an immunocompetent syngeneic mouse model of disseminated epithelial ovarian cancer (EOC) to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quinn, Bridget A, Xiao, Fang, Bickel, Laura, Martin, Lainie, Hua, Xiang, Klein-Szanto, Andres, Connolly, Denise C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974672/ https://www.ncbi.nlm.nih.gov/pubmed/20958993 http://dx.doi.org/10.1186/1757-2215-3-24

Ejemplares similares

A Syngeneic Mouse Model of Epithelial Ovarian Cancer Port Site Metastases
por: Wilkinson-Ryan, Ivy, et al.
Publicado: (2018)

Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
por: Cook, David P., et al.
Publicado: (2023)

Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer
por: Greenaway, James B., et al.
Publicado: (2016)

Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53
por: Quinn, Bridget A., et al.
Publicado: (2009)

Folate Receptor-Targeted Multimodality Imaging of Ovarian Cancer in a Novel Syngeneic Mouse Model
por: Ocak, Meltem, et al.
Publicado: (2014)

Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model
por: Lee, Yooyoung, et al.
Publicado: (2018)

Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model
por: Lin, Kai-Ti, et al.
Publicado: (2017)

Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer
por: Alvero, Ayesha B., et al.
Publicado: (2020)

Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model
por: Ranoa, Diana Rose E, et al.
Publicado: (2023)

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2021)

Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer
por: Russell, Shonagh, et al.
Publicado: (2022)

THE CYTOTOXIC EFFECT OF MOUSE MACROPHAGES ON SYNGENEIC AND ALLOGENEIC ERYTHROCYTES
por: Melsom, H., et al.
Publicado: (1973)

Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Radiation Responses of Subrenally Transplanted Syngeneic and Allogeneic Mouse Fibrosarcomas
por: Sato, Setsu, et al.
Publicado: (1988)

Single-Cell Landscape of Mouse Islet Allograft and Syngeneic Graft
por: Chen, Pengfei, et al.
Publicado: (2022)

Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model
por: Wilson, Andrew J, et al.
Publicado: (2013)

Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors
por: Zhong, Wenyan, et al.
Publicado: (2020)

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
por: Szymiczek, Agata, et al.
Publicado: (2017)

An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation
por: Fu, You, et al.
Publicado: (2020)

Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model
por: Nounamo, Bernice, et al.
Publicado: (2017)

Compound C Inhibits Renca Renal Epithelial Carcinoma Growth in Syngeneic Mouse Models by Blocking Cell Cycle Progression, Adhesion and Invasion
por: Lee, Myungyeon, et al.
Publicado: (2022)

Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
por: Rios-Doria, Jonathan, et al.
Publicado: (2015)

Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model
por: Al-Rayahi, Izzat A. M., et al.
Publicado: (2021)

Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models
por: Gutierrez, Wade R., et al.
Publicado: (2021)

Establishment and Validation of CyberKnife Irradiation in a Syngeneic Glioblastoma Mouse Model
por: Jelgersma, Claudius, et al.
Publicado: (2021)

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2021)

Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
por: du Chatinier, Aimée, et al.
Publicado: (2022)

A syngeneic MC38 orthotopic mouse model of colorectal cancer metastasis
por: Greenlee, Joshua D, et al.
Publicado: (2022)

Mouse Syngeneic Melanoma Model with Human Epidermal Growth Factor Receptor Expression
por: Slastnikova, Tatiana A., et al.
Publicado: (2022)

Machine learning on syngeneic mouse tumor profiles to model clinical immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2022)

DNA based neoepitope vaccination induces tumor control in syngeneic mouse models
por: Viborg, Nadia, et al.
Publicado: (2023)

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
por: Waaler, Jo, et al.
Publicado: (2020)

Effects of Dipeptidyl Peptidase-4 Inhibition with MK-0431 on Syngeneic Mouse Islet Transplantation
por: Juang, Jyuhn-Huarng, et al.
Publicado: (2014)

A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization
por: Ma, Wen-Tao, et al.
Publicado: (2017)

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
por: Regan, Jenna N., et al.
Publicado: (2017)

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
por: Piranlioglu, Raziye, et al.
Publicado: (2019)

A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host
por: Simons, Brian W., et al.
Publicado: (2019)

Anti-tumor effect of aquaporin 3 monoclonal antibody on syngeneic mouse tumor model
por: Tanaka, Manami, et al.
Publicado: (2022)

Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models
por: Chen, Apeng, et al.
Publicado: (2023)

Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer
por: Jung, Joon-Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bik3tb9vqqvl7orfo00avh4phv